These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 15611310)

  • 41. Rituximab therapy in patients with resistant rheumatoid arthritis: real-life experience.
    Jois RN; Masding A; Somerville M; Gaffney K; Scott DG
    Rheumatology (Oxford); 2007 Jun; 46(6):980-2. PubMed ID: 17384180
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Early rheumatoid arthritis: combination therapy of doxycycline plus methotrexate versus methotrexate monotherapy.
    Alarcón GS
    Nat Clin Pract Rheumatol; 2006 Jun; 2(6):296-7. PubMed ID: 16932705
    [No Abstract]   [Full Text] [Related]  

  • 43. A potential pitfall in the use of the Disease Activity Score (DAS28) as the main response criterion in treatment guidelines for patients with rheumatoid arthritis.
    Gardiner PV; Bell AL; Taggart AJ; Wright G; Kee F; Smyth A; McKane R; Lee J; Rooney ME; Whitehead E
    Ann Rheum Dis; 2005 Mar; 64(3):506-7. PubMed ID: 15708909
    [No Abstract]   [Full Text] [Related]  

  • 44. A disease activity index: its use in clinical trials and disease assessment in patients with rheumatoid arthritis.
    Davis MJ; Dawes PT
    Semin Arthritis Rheum; 1993 Oct; 23(2 Suppl 1):50-6. PubMed ID: 7904086
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [When to begin rheumatism treatment? Initial combination therapy helps fastest].
    Fath R
    MMW Fortschr Med; 2004 Sep; 146(37):5-6. PubMed ID: 15887691
    [No Abstract]   [Full Text] [Related]  

  • 46. [Management of severe synovial arthritis with drugs].
    Korpela M
    Duodecim; 2004; 120(6):707-14. PubMed ID: 15119232
    [No Abstract]   [Full Text] [Related]  

  • 47. Disease-modifying antirheumatic drugs.
    Brasington R
    J Hand Surg Am; 2009 Feb; 34(2):347-8. PubMed ID: 19181237
    [No Abstract]   [Full Text] [Related]  

  • 48. Rheumatoid arthritis: changing concepts of treatment.
    O'Connell PG
    Ir Med J; 1996; 89(6):206. PubMed ID: 8996942
    [No Abstract]   [Full Text] [Related]  

  • 49. Effect of anakinra on functional status in patients with active rheumatoid arthritis receiving concomitant therapy with traditional disease modifying antirheumatic drugs: evidence from the OMEGA Trial.
    Le Loët X; Nordström D; Rodriguez M; Rubbert A; Sarzi-Puttini P; Wouters JM; Woolley JM; Wright N; Lawrence C; Appleton B
    J Rheumatol; 2008 Aug; 35(8):1538-44. PubMed ID: 18634163
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Intra-articular infliximab in patients with rheumatoid arthritis and psoriatic arthritis with monoarthritis resistant to local glucocorticoids. Clinical efficacy extended to patients on systemic anti-tumour necrosis factor alpha.
    Conti F; Ceccarelli F; Priori R; Iagnocco A; Signore A; Valesini G
    Ann Rheum Dis; 2008 Dec; 67(12):1787-90. PubMed ID: 19005158
    [No Abstract]   [Full Text] [Related]  

  • 51. Progress toward the cure of rheumatoid arthritis? The BeSt study.
    Weisman MH
    Arthritis Rheum; 2005 Nov; 52(11):3326-32. PubMed ID: 16258928
    [No Abstract]   [Full Text] [Related]  

  • 52. Combination treatment strategies in early rheumatoid arthritis.
    Suresh E; Lambert CM
    Ann Rheum Dis; 2005 Sep; 64(9):1252-6. PubMed ID: 15860511
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The measure of our measures.
    Harth M; Pope J
    Rheumatology (Oxford); 2004 Dec; 43(12):1465-7. PubMed ID: 15479755
    [No Abstract]   [Full Text] [Related]  

  • 54. Clinical outcome and B cell depletion in patients with rheumatoid arthritis receiving rituximab monotherapy in comparison with patients receiving concomitant methotrexate.
    Owczarczyk K; Hellmann M; Fliedner G; Röhrs T; Maizus K; Passon D; Hallek M; Rubbert A
    Ann Rheum Dis; 2008 Nov; 67(11):1648-9. PubMed ID: 18854518
    [No Abstract]   [Full Text] [Related]  

  • 55. In quest of the Holy Grail: efficacy versus effectiveness in rheumatoid arthritis.
    Fleischmann R
    J Rheumatol; 2002 Sep; 29(9):2018-9; author reply 2019. PubMed ID: 12233903
    [No Abstract]   [Full Text] [Related]  

  • 56. Challenges of predicting treatment response in patients with rheumatoid arthritis.
    Smolen JS; Aletaha D
    Nat Clin Pract Rheumatol; 2005 Dec; 1(2):62-3. PubMed ID: 16932630
    [No Abstract]   [Full Text] [Related]  

  • 57. Improvement of vitiligo in a patient with rheumatoid arthritis after hydroxychloroquine treatment.
    Joo K; Park W; Kwon SR; Lim MJ; Jung KH
    Int J Rheum Dis; 2015 Jul; 18(6):679-80. PubMed ID: 25243922
    [No Abstract]   [Full Text] [Related]  

  • 58. Whither the ACR20?
    Felson DT
    J Rheumatol; 2004 May; 31(5):835-7. PubMed ID: 15124237
    [No Abstract]   [Full Text] [Related]  

  • 59. Hypoglycaemia induced by hydroxychloroquine in a non-diabetic patient treated for RA.
    Cansu DU; Korkmaz C
    Rheumatology (Oxford); 2008 Mar; 47(3):378-9. PubMed ID: 18222983
    [No Abstract]   [Full Text] [Related]  

  • 60. Canadian Consensus Conference on hydroxychloroquine.
    Canadian rheumatology association
    J Rheumatol; 2000 Dec; 27(12):2919-21. PubMed ID: 11128686
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.